HDAC9 and rheumatoid arthritis: Several HDAC inhibitors, such as HDAC6 inhibitors CKD-506 [119] and CKD-L [120] and HDAC6 inhibitor NK-HDAC1 [121], are currently being investigated as potential treatments for RA in pre-clinical studies.